ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,142Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 1111

$1.91M Total Retail Price of All Prescriptions

Rank: 5 out of 1111

835 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 835 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 835 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 25,742 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
FUROSEMIDE 1,115 928 1 6
LISINOPRIL 1,038 844 2 2
SIMVASTATIN 988 881 3 5
POTASSIUM CHLORIDE 983 842 4 9
OMEPRAZOLE 852 709 5 4
LEVOTHYROXINE SODIUM 844 711 6 3
DONEPEZIL HCL 709 671 7 25
HYDROCODONE-ACETAMINOPHEN 634 471 S3 8 1
SERTRALINE HCL 632 560 9 24
TRAMADOL HCL 631 470 10 13
AMLODIPINE BESYLATE 593 540 11 7
METFORMIN HCL 551 437 12 8
NAMENDA 537 462 13 31
CARVEDILOL 466 402 14 21
GABAPENTIN 458 371 15 10
WARFARIN SODIUM 441 365 16 19
MELOXICAM 438 372 17 18
ATORVASTATIN CALCIUM 372 335 18 15
RANITIDINE HCL 367 355 19 29
AMLODIPINE BESYLATE-BENAZEPRIL 340 294 20 67
HYDROCHLOROTHIAZIDE 302 288 21 11
CLOPIDOGREL 294 269 22 30
METOPROLOL TARTRATE 294 242 22 12
PRAVASTATIN SODIUM 268 217 24 17
METOPROLOL SUCCINATE 266 253 25 20
CITALOPRAM HBR 263 239 26 14
LANTUS 261 226 27 46
CRESTOR 259 185 28 33
DIVALPROEX SODIUM 245 211 29 82
NEXIUM 236 181 30 26
ESCITALOPRAM OXALATE 231 180 31 78
PLAVIX 223 207 32 49
NOVOLOG 220 194 33 104
FLUOXETINE HCL 216 119 34 44
ZOLPIDEM TARTRATE 213 124 35 16
DIGOXIN 213 211 35 47
CLONIDINE HCL 212 193 37 42
POLYETHYLENE GLYCOL 3350 210 167 38 45
FAZACLO 206 99 39 219
LISINOPRIL-HYDROCHLOROTHIAZIDE 202 185 40 23
ATENOLOL 193 140 41 22
LOSARTAN POTASSIUM 192 173 42 34
ALENDRONATE SODIUM 188 144 43 35
METOLAZONE 184 166 44 162
NAPROXEN 180 132 45 85
ALLOPURINOL 179 164 46 36
GLIPIZIDE 177 142 47 57
ADVAIR DISKUS 175 160 48 43
TAMSULOSIN HCL 168 168 49 28
RISPERIDONE 164 151 50 60
ROPINIROLE HCL 161 142 51 68
LYRICA 156 88 52 62
LEVETIRACETAM 154 41 53 111
DIOVAN 147 147 54 51
IBUPROFEN 143 124 55 66
LOSARTAN-HYDROCHLOROTHIAZIDE 134 117 56 72
BYSTOLIC 131 128 57 133
GLYBURIDE 127 115 R 58 59
PROAIR HFA 127 104 58 38
MIRTAZAPINE 126 123 60 52
FENTANYL 126 111 S2 60 65
PANTOPRAZOLE SODIUM 124 102 62 50
SPIRONOLACTONE 122 74 63 83
CLOTRIMAZOLE-BETAMETHASONE 121 99 64 194
CARBIDOPA-LEVODOPA 117 105 65 101
CYMBALTA 116 48 66 40
OLANZAPINE 112 82 67 117
NOVOLIN R 110 105 68 142
IPRATROPIUM-ALBUTEROL 107 93 69 161
JANUVIA 107 105 69 75
TRAZODONE HCL 105 89 71 32
QUETIAPINE FUMARATE 103 70 72 76
ZETIA 103 90 72 109
LIPITOR 102 93 74 116
LEXAPRO 102 80 74 208
ACTOS 101 92 76 98
ISOSORBIDE MONONITRATE ER 100 79 77 73
NABUMETONE 100 59 77 146
SULFAMETHOXAZOLE-TRIMETHOPRIM 100 86 77 71
SPIRIVA 96 85 80 53
AMITRIPTYLINE HCL 95 86 R 81 64
CELEBREX 95 76 81 81
GEMFIBROZIL 94 57 83 92
TIZANIDINE HCL 92 58 84 91
OXYBUTYNIN CHLORIDE 90 84 85 110
DIOVAN HCT 90 86 85 94
EXELON 88 84 87 121
PAROXETINE HCL 88 75 87 55
FLUTICASONE PROPIONATE 87 75 89 27
MUPIROCIN 86 77 90 154
LANTUS SOLOSTAR 85 59 91 135
LAMOTRIGINE 84 18 92 172
BENAZEPRIL HCL 83 71 93 97
AZITHROMYCIN 83 67 93 39
KLOR-CON M20 79 54 95 79
TRIAMTERENE-HCTZ 76 68 96 80
HUMALOG 73 28 97 202
GLIMEPIRIDE 73 72 97 61
DIVALPROEX SODIUM ER 72 24 99 171
HYDRALAZINE HCL 72 71 99 155
NITROFURANTOIN 71 67 101 265
PROPRANOLOL HCL 70 68 102 124
CIPROFLOXACIN HCL 69 57 103 58
PREDNISONE 69 63 103 48
LEVEMIR 68 57 105 132
PHENYTOIN SODIUM EXTENDED 66 55 106 126
GLYBURIDE-METFORMIN HCL 64 60 R 107 187
KLOR-CON 10 64 59 107 199
ABILIFY 63 51 109 123
TRIAMCINOLONE ACETONIDE 62 32 110 128
ONDANSETRON HCL 58 33 111 246
NOVOLIN N 57 57 112 276
RAMIPRIL 57 52 112 168
GLIPIZIDE ER 56 55 114 99
FENOFIBRATE 56 45 114 95
DILTIAZEM 24HR CD 55 55 116 152
AMIODARONE HCL 55 37 116 145
OXYBUTYNIN CHLORIDE ER 55 49 116 114
CYCLOBENZAPRINE HCL 53 33 R 119 37
NITROFURANTOIN MONO-MACRO 52 44 120 149
CAPTOPRIL 52 52 120 240
DETROL LA 51 51 122 139
DILTIAZEM 24HR ER 51 51 122 259
LANSOPRAZOLE 51 34 122 192
PREMARIN 50 50 R 125 90
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.